Harmony Corp (HRMY) - Forvard P/S multiplikatori

Harmony Biosciences (HRMY) - korporativ logo

Asosiy dori vositasining sotuvlaridan tushadigan barqaror pul oqimi forward P/S koeffitsienti orqali ifodalangan ijobiy dinamikani qo'llab-quvvatlaydi. Harmony Biosciences Wakix ning noyobligi tufayli mutlaq narx belgilash imkoniyatiga tayanadi. Harmony Biosciences strategiyasi yangi molekulalarni kashf etish va uyqu buzilishlari terapiyalarini kengaytirishga asoslangan. Shu bilan birga, 1.50 belgisi kelajakdagi daromadlar nisbatida kapitalizatsiyaga bo'lgan joriy bozor kutuvlarini belgilovchi asosiy ko'rsatkich vazifasini o'taydi.

Harmony Biosciences Holdings, Inc. - HRMY Kapitalizatsiyaning kutilayotgan sotuvga nisbati (davr: 04.07.2022 - 16.11.2026)

Harmony Biosciences kompaniyasining tahliliy kesimlari

Kompaniyaning barcha koʻrsatkichlari tahlili:Harmony Corp HRMY
Harmony Corp original mahsuloti

Bozor Harmony Biosciences (HRMY) kompaniyasini sug'urta jamg'armalarining kamyob nevrologik kasalliklar terapiyalarini moliyalashtirish qobiliyati prizmasi orqali baholaydi. Forward P/S koeffitsiyenti joriy bozor kapitalizatsiyasini kutilayotgan daromadlar bilan solishtirib, kelajakdagi pul oqimlariga bo'lgan bozor kutuvlarini aks ettiradi. Kompaniyaning kutilayotgan P/S koeffitsiyentini tahlil qilish orqali investor katapleksiya dori vositalariga bo'lgan talab dinamikasining real vaqtdagi bahosini oladi. Bu aktivning ob'ektiv baholash imkonini beradi va likvidlik past bo'lgan davrlarda haddan tashqari ko'p to'lov qilishning oldini oladi.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Biohaven Ltd - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Praxis Corp PRAX|AVXL: Forvard P/S multiplikatori|CBLL (ceribell.com) - Narxning prognoz qilingan daromadga nisbati|PRTA (Prothena Corporation) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori alector.com (ALEC)|Narxning prognoz qilingan daromadga nisbati Annexon, Inc. (ANNX)|OMER - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Voyager Therapeutics Inc - Forvard P/S multiplikatori|Neumora (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|TVGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori cogrx.com (CGTX)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cassava Sciences|Forvard P/S multiplikatori ASRT (Assertio Holdings)|COYA - Forvard narx/daromad multiplikatori|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori